Results 201 to 210 of about 88,283 (359)

A case of lactobezoar: Outpatient management in a neonate

open access: yesJPGN Reports, EarlyView.
Abstract A lactobezoar is a conglomerate of undigested and partially digested milk components and is the most common form of bezoar in infants. Described treatments include hospitalization for intravenous fluids and cessation of feeds, endoscopy with administration of N‐acetyl cysteine, and surgical or endoscopic removal.
Shivani Kamal   +3 more
wiley   +1 more source

Gastric Emptying and Lingual Lipase Activity in Cystic Fibrosis [PDF]

open access: bronze, 1980
M. Roulet   +6 more
openalex   +1 more source

In vitro radionuclide labeling characteristics of blenderized tube feeds for quantitative gastric motility assessment

open access: yesJPGN Reports, EarlyView.
Abstract Gastric emptying scintigraphy (GES) using technetium‐99m‐sulfur colloid (99mTc‐SC) is an important tool for evaluating feeding intolerance. Stable 99mTc‐SC binding to the solid component of the meal is imperative for accurate result interpretation.
Bridget M. Hron   +7 more
wiley   +1 more source

Decline in gut motility of cerebral palsy patients after a triggering event: A discussion on invasive versus conservative management

open access: yesJPGN Reports, EarlyView.
Abstract Objectives Patients with cerebral palsy (CP) often have gastrointestinal dysmotility. An inciting event, such as infection, may lead to progressive decline in bowel motility and episodes of acute pediatric intestinal pseudo‐obstruction (PIPO).
Zoe Saenz   +4 more
wiley   +1 more source

NON-MIGRAINE RELATED PAIN BEHAVIOURS IN A TRANSGENIC "MIGRAINE MOUSE" WITH CIRCADIAN DISRUPTION [PDF]

open access: yes, 2017
Goadsby, Peter J   +6 more
core   +1 more source

Optimizing Perioperative Management of Pancreatic Ductal Adenocarcinoma: Insights Into Modified FOLFIRINOX Relative Dose Intensity and CA 19‐9 Dynamics

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Background Many patients with resectable pancreatic ductal adenocarcinoma (PDAC) treated with modified FOLFIRINOX (mFOLFIRINOX) require dose reduction due to adverse effects. This study explores the optimal threshold for mFOLFIRINOX relative dose intensity (RDI) and characterizes RDI's correlation with CA 19‐9.
Jiage Qian   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy